vs
Jerash Holdings (US), Inc.（JRSH）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Jerash Holdings (US), Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍（$41.8M vs $35.5M），Jerash Holdings (US), Inc.净利率更高（2.8% vs -304.2%，领先307.0%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 18.0%），Jerash Holdings (US), Inc.自由现金流更多（$-3.9M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 39.1%）
Jerash Holdings (US), Inc. 是一家全球化服装制造商，为国际知名零售及服饰品牌生产高品质外套、运动服、休闲装及功能性服饰，核心市场覆盖北美、欧洲及亚太地区，在约旦及东南亚设有生产基地。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
JRSH vs RXRX — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.8M | $35.5M |
| 净利润 | $1.2M | $-108.1M |
| 毛利率 | 16.9% | 59.8% |
| 营业利润率 | 4.7% | -304.8% |
| 净利率 | 2.8% | -304.2% |
| 营收同比 | 18.0% | 681.7% |
| 净利润同比 | 20261.5% | 39.6% |
| 每股收益（稀释后） | $0.09 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $41.8M | $35.5M | ||
| Q3 25 | $42.0M | $5.2M | ||
| Q2 25 | $39.6M | $19.2M | ||
| Q1 25 | $29.3M | $14.7M | ||
| Q4 24 | $35.4M | $4.5M | ||
| Q3 24 | $40.2M | $26.1M | ||
| Q2 24 | $40.9M | $14.4M | ||
| Q1 24 | $21.6M | $13.8M |
| Q4 25 | $1.2M | $-108.1M | ||
| Q3 25 | $461.6K | $-162.3M | ||
| Q2 25 | $318.7K | $-171.9M | ||
| Q1 25 | $-152.6K | $-202.5M | ||
| Q4 24 | $-5.8K | $-178.9M | ||
| Q3 24 | $655.3K | $-95.8M | ||
| Q2 24 | $-1.3M | $-97.5M | ||
| Q1 24 | $-3.1M | $-91.4M |
| Q4 25 | 16.9% | 59.8% | ||
| Q3 25 | 15.0% | -183.8% | ||
| Q2 25 | 15.4% | -4.9% | ||
| Q1 25 | 17.9% | -48.0% | ||
| Q4 24 | 15.2% | -181.4% | ||
| Q3 24 | 17.5% | 53.7% | ||
| Q2 24 | 11.3% | 36.2% | ||
| Q1 24 | 7.0% | 19.1% |
| Q4 25 | 4.7% | -304.8% | ||
| Q3 25 | 2.6% | -3327.6% | ||
| Q2 25 | 2.4% | -916.8% | ||
| Q1 25 | 1.5% | -1297.9% | ||
| Q4 24 | 2.0% | -4042.4% | ||
| Q3 24 | 2.8% | -377.1% | ||
| Q2 24 | -2.0% | -697.4% | ||
| Q1 24 | -14.0% | -698.4% |
| Q4 25 | 2.8% | -304.2% | ||
| Q3 25 | 1.1% | -3135.3% | ||
| Q2 25 | 0.8% | -894.2% | ||
| Q1 25 | -0.5% | -1373.3% | ||
| Q4 24 | -0.0% | -3935.5% | ||
| Q3 24 | 1.6% | -367.5% | ||
| Q2 24 | -3.3% | -676.6% | ||
| Q1 24 | -14.3% | -662.4% |
| Q4 25 | $0.09 | $-0.17 | ||
| Q3 25 | $0.04 | $-0.36 | ||
| Q2 25 | $0.03 | $-0.41 | ||
| Q1 25 | $-0.01 | $-0.50 | ||
| Q4 24 | $0.00 | $-0.56 | ||
| Q3 24 | $0.05 | $-0.34 | ||
| Q2 24 | $-0.11 | $-0.40 | ||
| Q1 24 | $-0.25 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.5M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $63.6M | $1.1B |
| 总资产 | $84.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $11.5M | $743.3M | ||
| Q3 25 | $12.0M | $659.8M | ||
| Q2 25 | $5.8M | $525.1M | ||
| Q1 25 | $13.3M | $500.5M | ||
| Q4 24 | $13.2M | $594.4M | ||
| Q3 24 | $16.3M | $427.6M | ||
| Q2 24 | $11.4M | $474.3M | ||
| Q1 24 | $12.4M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $63.6M | $1.1B | ||
| Q3 25 | $62.8M | $1.0B | ||
| Q2 25 | $62.7M | $919.1M | ||
| Q1 25 | $62.8M | $933.9M | ||
| Q4 24 | $63.1M | $1.0B | ||
| Q3 24 | $63.4M | $524.6M | ||
| Q2 24 | $62.9M | $584.4M | ||
| Q1 24 | $64.4M | $401.2M |
| Q4 25 | $84.2M | $1.5B | ||
| Q3 25 | $83.3M | $1.4B | ||
| Q2 25 | $81.7M | $1.3B | ||
| Q1 25 | $83.0M | $1.3B | ||
| Q4 24 | $79.8M | $1.4B | ||
| Q3 24 | $80.3M | $726.5M | ||
| Q2 24 | $76.7M | $775.9M | ||
| Q1 24 | $80.2M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-3.9M | $-47.3M |
| 自由现金流率自由现金流/营收 | -9.3% | -133.1% |
| 资本支出强度资本支出/营收 | 0.2% | 3.5% |
| 现金转化率经营现金流/净利润 | -3.25× | — |
| 过去12个月自由现金流最近4个季度 | $-2.9M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-3.8M | $-46.1M | ||
| Q3 25 | $6.8M | $-117.4M | ||
| Q2 25 | $-6.5M | $-76.4M | ||
| Q1 25 | $1.9M | $-132.0M | ||
| Q4 24 | $-3.0M | $-115.4M | ||
| Q3 24 | $4.6M | $-59.2M | ||
| Q2 24 | $-2.2M | $-82.2M | ||
| Q1 24 | $-5.4M | $-102.3M |
| Q4 25 | $-3.9M | $-47.3M | ||
| Q3 25 | $6.4M | $-117.6M | ||
| Q2 25 | $-6.9M | $-79.6M | ||
| Q1 25 | $1.5M | $-133.8M | ||
| Q4 24 | $-3.2M | $-116.7M | ||
| Q3 24 | $4.4M | $-63.8M | ||
| Q2 24 | $-2.3M | $-83.4M | ||
| Q1 24 | $-5.8M | $-109.0M |
| Q4 25 | -9.3% | -133.1% | ||
| Q3 25 | 15.3% | -2272.5% | ||
| Q2 25 | -17.5% | -413.9% | ||
| Q1 25 | 5.1% | -907.4% | ||
| Q4 24 | -8.9% | -2567.7% | ||
| Q3 24 | 11.0% | -244.6% | ||
| Q2 24 | -5.7% | -578.5% | ||
| Q1 24 | -26.9% | -789.9% |
| Q4 25 | 0.2% | 3.5% | ||
| Q3 25 | 0.9% | 4.7% | ||
| Q2 25 | 1.2% | 16.4% | ||
| Q1 25 | 1.6% | 12.4% | ||
| Q4 24 | 0.4% | 28.6% | ||
| Q3 24 | 0.5% | 17.5% | ||
| Q2 24 | 0.3% | 8.2% | ||
| Q1 24 | 1.9% | 48.2% |
| Q4 25 | -3.25× | — | ||
| Q3 25 | 14.72× | — | ||
| Q2 25 | -20.33× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.06× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
